CHAM
CYTK icon

Clear Harbor Asset Management’s Cytokinetics CYTK Stock Holding History

Clear Harbor Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-550
Closed -$11.9K – 409
2020
Q3 		$11.9K Buy
+550
New +$12.9K ﹤0.01% 568
2020
Q1 		– Sell
-550
Closed -$5.84K – 365
2019
Q4 		$5.84K Buy
+550
New +$5.65K ﹤0.01% 659

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Clear Harbor Asset Management's CYTK Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Cytokinetics (CYTK) in Q4 2020, closing a stake of 550 shares — an estimated $11.9K sold.

Clear Harbor Asset Management first reported a position in CYTK in Q4 2019 and held it in 2 quarters. The position peaked at $11.9K in Q3 2020. 178 funds tracked by Wall St. Rank hold CYTK as of Q4 2020.

  • Clear Harbor Asset Management reported no remaining Cytokinetics position as of Q4 2020 after selling out during the quarter.
  • Clear Harbor Asset Management sold 550 Cytokinetics shares in Q4 2020, an estimated $11.9K.
  • Clear Harbor Asset Management first reported a position in Cytokinetics in Q4 2019 and held it in 2 quarters.
  • Clear Harbor Asset Management's Cytokinetics position peaked at $11.9K in Q3 2020.
  • 178 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.